Auto-injector pens win on ease. Vials win on cost. If you can handle a simple subcutaneous injection (spoiler: most people can), vials save you $100-700/month over pre-filled pens. LillyDirect's Zepbound vials at $299/month are the most affordable brand-name injectable GLP-1 option. For needle-phobic patients or those who want zero learning curve, pens are worth the premium.
When people picture GLP-1 injections, they usually imagine the auto-injector pen — click a button, medication is delivered, done. But there's a cheaper alternative that more patients are discovering: single-dose vials with standard insulin syringes. The medication is identical. The difference is in the delivery mechanism — and the price tag.
How Each Format Works
Auto-Injector Pens
Pre-filled pens (like Wegovy or Zepbound pens) contain a set number of doses. You dial your dose, press the pen against your skin, click the button, and the spring-loaded mechanism inserts the needle and delivers the medication automatically. No measuring, no visible needle during injection.
Vials and Syringes
Single-dose vials contain one dose of medication in a small glass container. You insert a standard insulin syringe (typically 29-31 gauge, very thin), draw up the correct volume, and self-inject subcutaneously. It requires basic technique — but the same technique millions of diabetic patients use daily for insulin.
Compounded Vials (Multi-Dose)
Compounded GLP-1 medications typically come in multi-dose vials that last 4-8 weeks. You draw up your prescribed dose with an insulin syringe for each injection. The process is identical to single-dose vials, but you're working from a larger container.
The Price Comparison
| Format | Medication | Monthly Cost |
|---|---|---|
| Auto-injector pen | Wegovy (injectable) | $349/mo (NovoCare) |
| Auto-injector pen | Zepbound (pen) | $399/mo (LillyDirect) |
| Single-dose vial | Zepbound (vial) | $299/mo (LillyDirect) ✓ |
| Compounded vial | Compounded semaglutide | $146-249/mo ✓ |
| Compounded vial | Compounded tirzepatide | $199-375/mo ✓ |
| Oral pill | Wegovy (oral) | $149/mo ✓ |
The Zepbound vial play: Eli Lilly specifically introduced single-dose Zepbound vials at $299/month to make tirzepatide more affordable. That's $100/month cheaper than the pen — or $1,200/year saved — for the exact same medication at the exact same dose.
Ease of Use Comparison
| Factor | Auto-Injector Pen | Vial + Syringe |
|---|---|---|
| Learning curve | Minimal ✓ | Moderate (5-10 min training) |
| Dose accuracy | Automatic, precise ✓ | Manual measurement required |
| Needle visibility | Hidden during injection ✓ | Visible |
| Injection speed | ~10 seconds ✓ | ~30-60 seconds |
| Dose flexibility | Fixed increments only | Any dose within range ✓ |
| Waste | Full pen discarded | Minimal waste ✓ |
| Travel convenience | Compact ✓ | Vial + syringes + alcohol swabs |
| Storage | Refrigerated | Refrigerated |
The Injection Isn't as Scary as You Think
The number one concern people have about vials is the injection itself. Here's the reality:
The needles are tiny. Insulin syringes use 29-31 gauge needles — thinner than most sewing needles. Subcutaneous injection goes into the fat layer just below the skin (usually the abdomen or thigh), not deep into muscle.
Most patients stop noticing after week 2. The anticipation is worse than the sensation. After a few injections, it becomes routine — comparable to brushing your teeth in terms of how much mental energy it requires.
Millions of people do this daily. Diabetic patients self-inject insulin with vials and syringes multiple times per day. GLP-1 patients inject once per week. If they can do it 7-14 times weekly, you can handle once.
When to Choose Pens
You have severe needle phobia. Not mild discomfort — actual phobia that would prevent you from following through with treatment. The hidden-needle mechanism of pens genuinely helps some patients.
Manual dexterity is limited. Arthritis, tremors, or other conditions that make it difficult to handle small syringes. Pen mechanisms require less fine motor skill.
You travel frequently. Pens are more compact and have fewer components to manage on the road.
Insurance covers the pen. If your insurer pays for Wegovy or Zepbound pens with minimal copay, there's no financial reason to switch to vials.
When to Choose Vials
You want to save money. This is the primary reason. Zepbound vials at $299 vs. pens at $399 saves $1,200/year. Compounded vials save even more.
You want dose flexibility. Vials allow your provider to prescribe precise, non-standard doses — useful during titration or if you need a dose between the fixed pen increments.
You're already comfortable with self-injection. If you've given yourself insulin, B12 shots, or any other injectable, the technique is identical.
You're using compounded GLP-1s. The majority of compounded GLP-1 medications come in vial form. Choosing compounded = choosing vials, in most cases.
Compare GLP-1 Providers by Format
Affiliate links · Prices verified March 2026
The Oral Alternative
If the entire injection debate is a dealbreaker, there's a third path: oral Wegovy at $149/month. Approved in December 2025, it's the first oral GLP-1 for weight loss. No needles, no vials, no pens — just a daily pill.
The trade-off: oral bioavailability is lower than injectable. Clinical trials showed meaningful but somewhat lower weight loss compared to injectable Wegovy. For many patients, the convenience trade-off is worth it.
See our injectable vs. oral comparison for the full breakdown.
Quick Decision Guide
| Your Priority | Best Format |
|---|---|
| Lowest cost, brand-name injectable | Zepbound vial ($299/mo) |
| Lowest cost overall | Compounded vial ($146-249/mo) |
| Easiest injection experience | Auto-injector pen |
| No injections at all | Oral Wegovy ($149/mo) |
| Maximum dose flexibility | Vial + syringe |
| Insurance covers it | Pen (standard covered format) |
The format you use matters less than the medication you take. Don't let delivery mechanism anxiety keep you from starting an effective GLP-1 program.